BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27789400)

  • 1. Establishment of SPAST mutant induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia (HSP) patient.
    Hauser S; Erzler M; Theurer Y; Schuster S; Schüle R; Schöls L
    Stem Cell Res; 2016 Nov; 17(3):485-488. PubMed ID: 27789400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous Y275X mutation in CYP7B1 (SPG5).
    Hauser S; Höflinger P; Theurer Y; Rattay TW; Schöls L
    Stem Cell Res; 2016 Sep; 17(2):437-440. PubMed ID: 27879220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous R486C mutation in CYP7B1 (SPG5).
    Höflinger P; Theurer Y; Schüle R; Schöls L; Hauser S
    Stem Cell Res; 2016 Sep; 17(2):422-425. PubMed ID: 27879216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a M146I mutation in PSEN1.
    Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Holst B; Hyttel P; Freude KK
    Stem Cell Res; 2016 Mar; 16(2):334-7. PubMed ID: 27345998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of optic atrophy 1 patient-derived induced pluripotent stem cells (iPS-OPA1-BEHR) for disease modeling of complex optic atrophy syndromes (Behr syndrome).
    Hauser S; Schuster S; Theurer Y; Synofzik M; Schöls L
    Stem Cell Res; 2016 Sep; 17(2):426-429. PubMed ID: 27879217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a L150P mutation in PSEN-1.
    Tubsuwan A; Pires C; Rasmussen MA; Schmid B; Nielsen JE; Hjermind LE; Hall V; Nielsen TT; Waldemar G; Hyttel P; Clausen C; Kitiyanant N; Freude KK; Holst B
    Stem Cell Res; 2016 Jan; 16(1):110-2. PubMed ID: 27345792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN1.
    Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Hyttel P; Freude KK
    Stem Cell Res; 2016 Mar; 16(2):229-32. PubMed ID: 27345973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spastic paraplegia type 4: A novel SPAST splice site donor mutation and expansion of the phenotype variability.
    Kawarai T; Montecchiani C; Miyamoto R; Gaudiello F; Caltagirone C; Izumi Y; Kaji R; Orlacchio A
    J Neurol Sci; 2017 Sep; 380():92-97. PubMed ID: 28870597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence variants in SPAST, SPG3A and HSPD1 in hereditary spastic paraplegia.
    Svenstrup K; Bross P; Koefoed P; Hjermind LE; Eiberg H; Born AP; Vissing J; Gyllenborg J; Nørremølle A; Hasholt L; Nielsen JE
    J Neurol Sci; 2009 Sep; 284(1-2):90-5. PubMed ID: 19423133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of spastin function results in disease-specific axonal defects in human pluripotent stem cell-based models of hereditary spastic paraplegia.
    Denton KR; Lei L; Grenier J; Rodionov V; Blackstone C; Li XJ
    Stem Cells; 2014 Feb; 32(2):414-23. PubMed ID: 24123785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mutations in the SPAST gene cause hereditary spastic paraplegia.
    Zhu Z; Zhang C; Zhao G; Liu Q; Zhong P; Zhang M; Tang W; Zhan F; Tian W; Wang Y; Yin K; Huang X; Jiang J; Liu X; Liu S; Zhou H; Luan X; Tang H; Wang Y; Chen S; Cao L
    Parkinsonism Relat Disord; 2019 Dec; 69():125-133. PubMed ID: 31751864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of two SPAST knockout human induced pluripotent stem cell lines to create a model for Hereditary Spastic Paraplegia type 4.
    Korneck M; Wiora L; Schöls L; Hauser S
    Stem Cell Res; 2022 Apr; 60():102741. PubMed ID: 35248878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Japanese SPG4 Patient with a Confirmed De Novo Mutation of the SPAST Gene.
    Nan H; Okamoto K; Gao L; Morishima Y; Ichinose Y; Koh K; Hashiyada M; Adachi N; Takiyama Y
    Intern Med; 2020 Sep; 59(18):2311-2315. PubMed ID: 32522921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivation of induced pluripotent stem cells from a familial Alzheimer's disease patient carrying the L282F mutation in presenilin 1.
    Poon A; Li T; Pires C; Nielsen TT; Nielsen JE; Holst B; Dinnyes A; Hyttel P; Freude KK
    Stem Cell Res; 2016 Nov; 17(3):470-473. PubMed ID: 27789396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel missense mutation in
    Wang XC; Liu RH; Wang T; Wang Y; Jiang Y; Chen DD; Wang XY; Hou TS; Kong QX
    Mol Med Rep; 2023 Apr; 27(4):. PubMed ID: 36825575
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Nakazeki F; Tsuge I; Horie T; Imamura K; Tsukita K; Hotta A; Baba O; Kuwabara Y; Nishino T; Nakao T; Nishiga M; Nishi H; Nakashima Y; Ide Y; Koyama S; Kimura M; Tsuji S; Naitoh M; Suzuki S; Izumi Y; Kawarai T; Kaji R; Kimura T; Inoue H; Ono K
    Clin Sci (Lond); 2019 Feb; 133(4):583-595. PubMed ID: 30777884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induced pluripotent stem cells (iPSCs) derived from cerebrotendinous xanthomatosis (CTX) patient's fibroblasts carrying a R395S mutation.
    Höflinger P; Hauser S; Theurer Y; Weißenberger S; Wilke C; Schöls L
    Stem Cell Res; 2016 Sep; 17(2):433-436. PubMed ID: 27879219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of dermal fibroblast-derived iPSCs from a patient with low grade steatosis.
    Kawala MA; Bohndorf M; Graffmann N; Wruck W; Zatloukal K; Adjaye J
    Stem Cell Res; 2016 Nov; 17(3):547-549. PubMed ID: 27789406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of an iPSC line from a patient with tyrosine hydroxylase (TH) deficiency: TH-1 iPSC.
    Jung-Klawitter S; Blau N; Sebe A; Ebersold J; Göhring G; Opladen T
    Stem Cell Res; 2016 Nov; 17(3):580-583. PubMed ID: 27934587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of an integration-free induced pluripotent stem cell line, FJMUi001-A, from a hereditary spastic paraplegia patient carrying compound heterozygous p.P498L and p.R618W mutations in CAPN1 (SPG76).
    Lu YQ; Dong EL; Yang WQ; Lai LL; Lin XH; Ma LX; Chen WJ; Wang N; Lin X
    Stem Cell Res; 2019 Jan; 34():101354. PubMed ID: 30611022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.